BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 10717387)

  • 1. Loss of the Fanconi anemia group C protein activity results in an inability to activate caspase-3 after ionizing radiation.
    Guillouf C; Vit JP; Rosselli F
    Biochimie; 2000 Jan; 82(1):51-8. PubMed ID: 10717387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-gamma-induced apoptotic responses of Fanconi anemia group C hematopoietic progenitor cells involve caspase 8-dependent activation of caspase 3 family members.
    Rathbun RK; Christianson TA; Faulkner GR; Jones G; Keeble W; O'Dwyer M; Bagby GC
    Blood; 2000 Dec; 96(13):4204-11. PubMed ID: 11110692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Futile caspase-8 activation during the apoptotic cell death induced by DNA damaging agents in human B-lymphoblasts.
    Vit JP; Guillouf C; Rosselli F
    Exp Cell Res; 2001 Sep; 269(1):2-12. PubMed ID: 11525634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fanconi anemia group A and C double-mutant mice: functional evidence for a multi-protein Fanconi anemia complex.
    Noll M; Battaile KP; Bateman R; Lax TP; Rathbun K; Reifsteck C; Bagby G; Finegold M; Olson S; Grompe M
    Exp Hematol; 2002 Jul; 30(7):679-88. PubMed ID: 12135664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for the Fanconi anemia C protein in maintaining the DNA damage-induced G2 checkpoint.
    Freie BW; Ciccone SL; Li X; Plett PA; Orschell CM; Srour EF; Hanenberg H; Schindler D; Lee SH; Clapp DW
    J Biol Chem; 2004 Dec; 279(49):50986-93. PubMed ID: 15377654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fanconi's anemia cell lines show distinct mechanisms of cell death in response to mitomycin C or agonistic anti-Fas antibodies.
    Clarke AA; Gibson FM; Scott J; Myatt N; Rutherford TR
    Haematologica; 2004 Jan; 89(1):11-20. PubMed ID: 14754601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fanconi anemia type C-deficient hematopoietic cells are resistant to TRAIL (TNF-related apoptosis-inducing ligand)-induced cleavage of pro-caspase-8.
    Platzbecker U; Kurre P; Guardiola P; Ward JL; Radich JP; Kiem HP; Deeg HJ
    Exp Hematol; 2004 Sep; 32(9):815-21. PubMed ID: 15345282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG.
    de Winter JP; van der Weel L; de Groot J; Stone S; Waisfisz Q; Arwert F; Scheper RJ; Kruyt FA; Hoatlin ME; Joenje H
    Hum Mol Genet; 2000 Nov; 9(18):2665-74. PubMed ID: 11063725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the Fanconi anemia group C protein through proteolytic modification.
    Brodeur I; Goulet I; Tremblay CS; Charbonneau C; Delisle MC; Godin C; Huard C; Khandjian EW; Buchwald M; Lévesque G; Carreau M
    J Biol Chem; 2004 Feb; 279(6):4713-20. PubMed ID: 14625294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.
    Garcia-Higuera I; Taniguchi T; Ganesan S; Meyn MS; Timmers C; Hejna J; Grompe M; D'Andrea AD
    Mol Cell; 2001 Feb; 7(2):249-62. PubMed ID: 11239454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by gamma interferon and hematopoietic growth factors.
    Pang Q; Fagerlie S; Christianson TA; Keeble W; Faulkner G; Diaz J; Rathbun RK; Bagby GC
    Mol Cell Biol; 2000 Jul; 20(13):4724-35. PubMed ID: 10848598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.
    Adachi D; Oda T; Yagasaki H; Nakasato K; Taniguchi T; D'Andrea AD; Asano S; Yamashita T
    Hum Mol Genet; 2002 Dec; 11(25):3125-34. PubMed ID: 12444097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis.
    Freie B; Li X; Ciccone SL; Nawa K; Cooper S; Vogelweid C; Schantz L; Haneline LS; Orazi A; Broxmeyer HE; Lee SH; Clapp DW
    Blood; 2003 Dec; 102(12):4146-52. PubMed ID: 12855557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality.
    Pang Q; Christianson TA; Keeble W; Diaz J; Faulkner GR; Reifsteck C; Olson S; Bagby GC
    Blood; 2001 Sep; 98(5):1392-401. PubMed ID: 11520787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fanconi anemia C protein acts at a switch between apoptosis and necrosis in mitomycin C-induced cell death.
    Guillouf C; Wang TS; Liu J; Walsh CE; Poirier GG; Moustacchi E; Rosselli F
    Exp Cell Res; 1999 Feb; 246(2):384-94. PubMed ID: 9925754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage- and cell cycle-regulated manner.
    Qiao F; Moss A; Kupfer GM
    J Biol Chem; 2001 Jun; 276(26):23391-6. PubMed ID: 11297559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex.
    Garcia-Higuera I; Kuang Y; Näf D; Wasik J; D'Andrea AD
    Mol Cell Biol; 1999 Jul; 19(7):4866-73. PubMed ID: 10373536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yeast two-hybrid screens imply involvement of Fanconi anemia proteins in transcription regulation, cell signaling, oxidative metabolism, and cellular transport.
    Reuter TY; Medhurst AL; Waisfisz Q; Zhi Y; Herterich S; Hoehn H; Gross HJ; Joenje H; Hoatlin ME; Mathew CG; Huber PA
    Exp Cell Res; 2003 Oct; 289(2):211-21. PubMed ID: 14499622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A patient-derived mutant form of the Fanconi anemia protein, FANCA, is defective in nuclear accumulation.
    Kupfer G; Naf D; Garcia-Higuera I; Wasik J; Cheng A; Yamashita T; Tipping A; Morgan N; Mathew CG; D'Andrea AD
    Exp Hematol; 1999 Apr; 27(4):587-93. PubMed ID: 10210316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.